LYEL Chart
- 52-Week Range: $0.00 - $0.00
- Market Capitalization: $1.01B
- Short Percentage: 0%
- Target Price: $17.33
- Shares Outstanding: 246.14M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
LYEL released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Lyell Immunopharma to Participate in BofA Securities Healthcare ConferenceGlobeNewsWire | May 4th
- Lyell Immunopharma Appoints Gary Lee, Ph.D. as Chief Scientific OfficerGlobeNewsWire | January 31st
- Lyell Immunopharma Announces Return of Dr. Rick Klausner as Board ChairGlobeNewsWire | December 2nd
- Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire | November 12th
- Lyell Immunopharma to Participate in Morgan Stanley Global Healthcare ConferenceGlobeNewsWire | September 8th
- Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire | August 12th
Company Info
Website: https://www.lyell.com
Address: 201 Haskins Way, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 219
Address: 201 Haskins Way, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 219
$LYEL we need to get moving
$LYEL how low can she go
$LYEL let’s gooooo
$LYEL the catalyst we need !
$LYEL let’s gooooo
$LYEL Same thing
different day
$LYEL will go green when market opens!